BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25409837)

  • 1. Re: postoperative complications do not affect long-term outcome in esophageal cancer patients.
    Pucher PH; Ferri LE; Aggarwal R
    World J Surg; 2015 May; 39(5):1320-1. PubMed ID: 25409837
    [No Abstract]   [Full Text] [Related]  

  • 2. Postoperative complications do not affect long-term outcome in esophageal cancer patients: reply.
    Lindner K; Fritz M; Haane C; Senninger N; Palmes D; Hummel R
    World J Surg; 2015 May; 39(5):1322-4. PubMed ID: 25631941
    [No Abstract]   [Full Text] [Related]  

  • 3. Postoperative complications do not affect long-term outcome in esophageal cancer patients.
    Lindner K; Fritz M; Haane C; Senninger N; Palmes D; Hummel R
    World J Surg; 2014 Oct; 38(10):2652-61. PubMed ID: 24867467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.
    Koëter M; van der Sangen MJ; Hurkmans CW; Luyer MD; Rutten HJ; Nieuwenhuijzen GA
    Radiat Oncol; 2015 Mar; 10():59. PubMed ID: 25884226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Combination of Respiratory Comorbidity and Neoadjuvant Chemoradiotherapy May Double the Risk of Anastomotic Leaks After Esophagectomy: Do We Know Enough to Tailor Neoadjuvant Therapies, or Take Other Preemptive Measures in High-Risk Patients?
    Nilsson M
    Ann Surg Oncol; 2019 Sep; 26(9):2660-2661. PubMed ID: 31228133
    [No Abstract]   [Full Text] [Related]  

  • 6. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers.
    Kumagai K; Rouvelas I; Tsai JA; Mariosa D; Klevebro F; Lindblad M; Ye W; Lundell L; Nilsson M
    Br J Surg; 2014 Mar; 101(4):321-38. PubMed ID: 24493117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
    Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
    Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
    Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
    Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally Invasive Esophagectomy: Is There an Advantage?
    Battafarano RJ
    Adv Surg; 2016 Sep; 50(1):17-28. PubMed ID: 27520859
    [No Abstract]   [Full Text] [Related]  

  • 11. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
    Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer.
    Smithers BM; Thomson I
    Thorac Surg Clin; 2013 Nov; 23(4):509-23. PubMed ID: 24199701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Techniques and short-term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastroesophageal junction cancers: pooled data from six European centers.
    Straatman J; van der Wielen N; Nieuwenhuijzen GA; Rosman C; Roig J; Scheepers JJ; Cuesta MA; Luyer MD; van Berge Henegouwen MI; van Workum F; Gisbertz SS; van der Peet DL
    Surg Endosc; 2017 Jan; 31(1):119-126. PubMed ID: 27129563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety.
    Brown RE; Abbas AE; Ellis S; Williams S; Scoggins CR; McMasters KM; Martin RC
    J Am Coll Surg; 2011 Apr; 212(4):582-8; discussion 588-9. PubMed ID: 21463793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Timing of esophagectomy in multimodal therapy of esophageal cancer: Impact of time interval between neoadjuvant therapy and surgery on outcome and response].
    Müller AK; Lenschow C; Palmes D; Senninger N; Hummel R; Lindner K
    Chirurg; 2015 Sep; 86(9):874-80. PubMed ID: 25662991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.
    Vallböhmer D; Hölscher AH; DeMeester S; DeMeester T; Salo J; Peters J; Lerut T; Swisher SG; Schröder W; Bollschweiler E; Hofstetter W
    Ann Surg; 2010 Nov; 252(5):744-9. PubMed ID: 21037429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemoradiotherapy followed by esophagectomy does not increase morbidity in patients over 70.
    Blom RL; van Heijl M; Klinkenbijl JH; Bergman JJ; Wilmink JW; Richel DJ; Hulshof MC; Reitsma JB; Busch OR; van Berge Henegouwen MI
    Dis Esophagus; 2013 Jul; 26(5):510-6. PubMed ID: 22925313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies for esophageal cancer.
    Nieman DR; Peters JH
    Gastroenterol Clin North Am; 2013 Mar; 42(1):187-97. PubMed ID: 23452638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally Invasive Esophagectomy: A New Era of Surgical Resection.
    Treitl D; Hurtado M; Ben-David K
    J Laparoendosc Adv Surg Tech A; 2016 Apr; 26(4):276-80. PubMed ID: 27046331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic strategies for squamous cell cancer and adenocarcinoma.
    Wijnhoven BPL; Toxopeus ELA; Vallböhmer D; Knoefel WT; Krasna MJ; Perez K; van Rossum PSN; Ruurda JP; van Hillegersberg R; Schiesser M; Schneider P; Felix VN
    Ann N Y Acad Sci; 2013 Oct; 1300():213-225. PubMed ID: 24117644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.